Vassilevski AA - Search Results

1

Molecules to selectively target receptors for treatment of pain and neurogenic inflammation.

Andreev YA, Vassilevski AA, Kozlov SA. Andreev YA, et al. Among authors: vassilevski aa. Recent Pat Inflamm Allergy Drug Discov. 2012 Jan;6(1):35-45. doi: 10.2174/187221312798889266. Recent Pat Inflamm Allergy Drug Discov. 2012. PMID: 22185455 Review.

2

Latarcins, antimicrobial and cytolytic peptides from the venom of the spider Lachesana tarabaevi (Zodariidae) that exemplify biomolecular diversity.

Kozlov SA, Vassilevski AA, Feofanov AV, Surovoy AY, Karpunin DV, Grishin EV. Kozlov SA, et al. Among authors: vassilevski aa. J Biol Chem. 2006 Jul 28;281(30):20983-20992. doi: 10.1074/jbc.M602168200. Epub 2006 May 30. J Biol Chem. 2006. PMID: 16735513 Free article.

3

Cyto-insectotoxins, a novel class of cytolytic and insecticidal peptides from spider venom.

Vassilevski AA, Kozlov SA, Samsonova OV, Egorova NS, Karpunin DV, Pluzhnikov KA, Feofanov AV, Grishin EV. Vassilevski AA, et al. Biochem J. 2008 May 1;411(3):687-96. doi: 10.1042/bj20071123. Biochem J. 2008. PMID: 18215128

4

Bacterial production of latarcin 2a, a potent antimicrobial peptide from spider venom.

Shlyapnikov YM, Andreev YA, Kozlov SA, Vassilevski AA, Grishin EV. Shlyapnikov YM, et al. Among authors: vassilevski aa. Protein Expr Purif. 2008 Jul;60(1):89-95. doi: 10.1016/j.pep.2008.03.011. Epub 2008 Mar 25. Protein Expr Purif. 2008. PMID: 18455432

5

Antimicrobial peptide precursor structures suggest effective production strategies.

Vassilevski AA, Kozlov SA, Grishin EV. Vassilevski AA, et al. Recent Pat Inflamm Allergy Drug Discov. 2008 Jan;2(1):58-63. doi: 10.2174/187221308783399261. Recent Pat Inflamm Allergy Drug Discov. 2008. PMID: 19075992 Review.

6

Purification and characterization of biologically active peptides from spider venoms.

Vassilevski AA, Kozlov SA, Egorov TA, Grishin EV. Vassilevski AA, et al. Methods Mol Biol. 2010;615:87-100. doi: 10.1007/978-1-60761-535-4_7. Methods Mol Biol. 2010. PMID: 20013202

7

Molecular diversity of spider venom.

Vassilevski AA, Kozlov SA, Grishin EV. Vassilevski AA, et al. Biochemistry (Mosc). 2009 Dec;74(13):1505-34. doi: 10.1134/s0006297909130069. Biochemistry (Mosc). 2009. PMID: 20210706 Free article. Review.

8

Cyanogen bromide cleavage of proteins in salt and buffer solutions.

Andreev YA, Kozlov SA, Vassilevski AA, Grishin EV. Andreev YA, et al. Among authors: vassilevski aa. Anal Biochem. 2010 Dec 1;407(1):144-6. doi: 10.1016/j.ab.2010.07.023. Epub 2010 Jul 27. Anal Biochem. 2010. PMID: 20670609

9

Spider venom peptides for gene therapy of Chlamydia infection.

Lazarev VN, Polina NF, Shkarupeta MM, Kostrjukova ES, Vassilevski AA, Kozlov SA, Grishin EV, Govorun VM. Lazarev VN, et al. Among authors: vassilevski aa. Antimicrob Agents Chemother. 2011 Nov;55(11):5367-9. doi: 10.1128/AAC.00449-11. Epub 2011 Aug 29. Antimicrob Agents Chemother. 2011. PMID: 21876050 Free PMC article.

10

Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.

Dubovskii PV, Vassilevski AA, Samsonova OV, Egorova NS, Kozlov SA, Feofanov AV, Arseniev AS, Grishin EV. Dubovskii PV, et al. Among authors: vassilevski aa. FEBS J. 2011 Nov;278(22):4382-93. doi: 10.1111/j.1742-4658.2011.08361.x. Epub 2011 Oct 17. FEBS J. 2011. PMID: 21933345 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page